NCT06427005 2025-01-22Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRCWest China HospitalPhase 2 Recruiting66 enrolled
NCT03941561 2019-05-31S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC)Fudan UniversityPhase 3 Recruiting1,006 enrolled